You have 9 free searches left this month | for more free features.

QR-110

Showing 1 - 25 of 551

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis Trial in Iowa City, Philadelphia, Ghent (QR-110)

Active, not recruiting
  • Leber Congenital Amaurosis 10
  • +9 more
  • QR-110
  • Iowa City, Iowa
  • +2 more
Feb 8, 2022

Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis Trial in Worldwide (sepofarsen, Sham)

Active, not recruiting
  • Leber Congenital Amaurosis 10
  • +9 more
  • Iowa City, Iowa
  • +13 more
Mar 2, 2022

Leber's Congenital Amaurosis Trial in Iowa City, Philadelphia, Ghent (QR-110)

Completed
  • Leber's Congenital Amaurosis
  • QR-110
  • Iowa City, Iowa
  • +2 more
Oct 13, 2020

Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis Trial in Worldwide (sepofarsen)

Recruiting
  • Leber Congenital Amaurosis 10
  • +10 more
  • Ghent, Belgium
  • +8 more
Mar 24, 2022

Pain Trial (GoodFOR Pain, Icy Hot, Tiger Balm)

Not yet recruiting
  • Pain
  • GoodFOR Pain
  • +7 more
  • (no location specified)
Jun 6, 2022

Head Neck Cancer, Quality of Life, Pain Trial in Kaohsiung (Hydrogen Inhalation, Ordinary Air Inhalation)

Recruiting
  • Head and Neck Cancer
  • +4 more
  • Hydrogen Inhalation
  • Ordinary Air Inhalation
  • Kaohsiung, Taiwan
    Kaohsiung Medical University Chung-Ho Memorial Hospital
Feb 10, 2023

Bunion Trial in Bellaire (Ropivacaine)

Recruiting
  • Bunion
  • Bellaire, Texas
    First Surgical Hospital 4801 Bissonnet Street
Mar 6, 2023

Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Canada, France, United States (QR-421a, Sham-procedure (dose

Completed
  • Retinitis Pigmentosa
  • +7 more
  • QR-421a
  • Sham-procedure (dose cohort 1&2 only)
  • Boston, Massachusetts
  • +6 more
Apr 19, 2022

Contraceptive Usage Trial in Fort Worth (Tuune Supplemented Contraceptive Visit, Traditional Contraceptive Visit)

Not yet recruiting
  • Contraceptive Usage
  • Tuune Supplemented Contraceptive Visit
  • Traditional Contraceptive Visit
  • Fort Worth, Texas
    Texas Christian University
Jul 31, 2023

Retinitis Pigmentosa, Usher Syndrome Type 2 Trial in Canada, France, United States (RNA antisense oligonucleotide for

Terminated
  • Retinitis Pigmentosa
  • Usher Syndrome Type 2
  • RNA antisense oligonucleotide for intravitreal injection
  • Boston, Massachusetts
  • +6 more
Dec 12, 2022

Cystic Fibrosis Trial in Belgium, France, United States (QR-010)

Completed
  • Cystic Fibrosis
  • Birmingham, Alabama
  • +4 more
Sep 2, 2020

Musculoskeletal Diseases or Conditions Trial (Educational Tool)

Not yet recruiting
  • Musculoskeletal Diseases or Conditions
  • Educational Tool
  • (no location specified)
Jun 19, 2023

Refractory Chronic Cough Trial in Phoenix, Leesburg, Winter Park (3 mg NOC-100 (via nebulizer), 1 mg NOC-110 (via DPI) [1x 1 mg

Completed
  • Refractory Chronic Cough
  • 3 mg NOC-100 (via nebulizer)
  • +5 more
  • Phoenix, Arizona
  • +2 more
Nov 16, 2022

Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Dallas, Madison, London (QR-421a, Sham-procedure)

Active, not recruiting
  • Retinitis Pigmentosa
  • +7 more
  • Dallas, Texas
  • +2 more
Apr 21, 2022

Cardiopulmonary Function and Quality of Life in Patients

Active, not recruiting
  • COVID-19
  • None intervation
  • Lima Lima, Lima, Peru
    Instituto de Medicina Tropical Alexander von Humboldt, Universid
Aug 28, 2022

Acute Myeloid Leukemia, Myeloid Dysplastic Syndrome Trial in Worldwide (Guadecitabine)

Terminated
  • Acute Myeloid Leukemia
  • Myeloid Dysplastic Syndrome
  • Buffalo, New York
  • +20 more
Jan 21, 2022

Blood Pressure, Perioperative Hypotension Trial in Hamburg (Continuous norepinephrine infusion via an infusion pump, Manual

Not yet recruiting
  • Blood Pressure
  • Perioperative Hypotension
  • Continuous norepinephrine infusion via an infusion pump
  • Manual bolus norepinephrine administration
  • Hamburg, Germany
    Universitätsklinikum Hamburg-Eppendorf
Aug 10, 2023

Neovascular Age-related Macular Degeneration (nAMD) Trial in Abilene (OCU-10-C-110 for Injection)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • OCU-10-C-110 for Injection
  • Abilene, Texas
    Retina Research Institute of Texas
Jun 6, 2023

Atrial Fibrillation, Hemostasis Trial in Overland Park, Independence, Kansas City (Vascular closure with LockeT device)

Recruiting
  • Atrial Fibrillation
  • Hemostasis
  • Vascular closure with LockeT device
  • Overland Park, Kansas
  • +5 more
Oct 3, 2023

Heart Failure Trial in Shatin (Dapagliflozin)

Not yet recruiting
  • Heart Failure
  • Shatin, Hong Kong
    The Chinese University of Hong Kong
Feb 24, 2023

Depression Trial in Paris (MAP4343, Placebo)

Recruiting
  • Depression
  • Paris, France
    APHP La Pitié Salpétrière
Nov 10, 2022

Glabellar Frown Lines Trial in Seoul (ATGC-110, Xeomin®)

Active, not recruiting
  • Glabellar Frown Lines
  • ATGC-110
  • Xeomin®
  • Seoul, Korea, Republic of
    Nowon Eulji Medical Center
Feb 2, 2023

Tourette Syndrome Trial in Hannover, Tel Aviv (SCI-110, Placebo)

Not yet recruiting
  • Tourette Syndrome
  • Hannover, Germany
  • +1 more
Oct 25, 2022

Food Insecurity Trial in San Francisco (Monetary benefit to purchase fruits and vegetables)

Not yet recruiting
  • Food Insecurity
  • Monetary benefit to purchase fruits and vegetables
  • San Francisco, California
    University of California, San Francisco
Jul 28, 2023

Methylmalonic Acidemia (MMA) Trial run by the Selecta Biosciences, Inc. (SEL-302)

Recruiting
  • Methylmalonic Acidemia (MMA)
  • Bethesda, Maryland
    National Human Genome Research Institute, National Institutes of
Mar 9, 2023